| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Johnson & Johnson (JNJ) has 22 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. JNJ is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.04M | $899.13M | - | |
| VP | 194.4K | $43.25M | - | |
| CEO | 79.6K | $17.72M | - | |
| VP | 46.2K | $10.28M | - | |
| VP | 32.5K | $7.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Taubert Jennifer L60 | EVP, Wwc. Innovative Medicine | Sale+OE | 56,471 | $177.81 | $10,040,882.63 | -24.1% | +14.9% | - | |
| Aug 22, 2025 | Duato Joaquin | CEO And Chairman Of The Board | Sale+OE | 125,824 | $179.21 | $22,548,654.81 | -31.3% | +13.3% | - | |
| Aug 15, 2025 | Wolk Joseph J | Exec VP, CFO | Sale+OE | 16,820 | $176.91 | $2,975,570.69 | -54.6% | +10.5% | - | |
| Jul 17, 2025 | Reed John C | EVP, Innovative Medicine, R&D | Sell | 19,137 | $163.55 | $3,129,829.56 | -64.2% | +17.3% | - | |
| Feb 25, 2025 | Decker Robert J56 | VP Corporate Controller | Sale+OE | 6,999 | $165.88 | $1,160,994.12 | -25.0% | -7.7% | +47.6% | |
| Feb 18, 2025 | Schmid Timothy | EVP, Ww Chair, Medtech | Sale+OE | 403 | $156.15 | $62,928.45 | -2.6% | -1.6% | +58.1% | |
| Feb 7, 2025 | Wolk Joseph J | Exec VP, CFO | Sale+OE | 13,015 | $153.89 | $2,002,878.35 | -100% | +1.7% | +56.7% | |
| Dec 12, 2024 | Weinberger Mark A | Director | Buy | 1,000 | $147.22 | $147,220.00 | New | +11.4% | +44.7% | |
| Aug 30, 2024 | Decker Robert J56 | VP Corporate Controller | Sale+OE | 5,635 | $165.06 | $930,113.10 | -22.9% | -6.5% | +6.8% | |
| Mar 13, 2024 | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | 8,891 | $162.16 | $1,441,764.56 | -37.1% | -8.9% | +1.2% |